Detalles de la búsqueda
1.
Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite.
Pharm Res
; 39(9): 2147-2162, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790618
2.
Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers.
Acta Pharmacol Sin
; 43(4): 1082-1090, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34267345
3.
Drug interaction of ningetinib and gefitinib involving CYP1A1 and efflux transporters in non-small cell lung cancer patients.
Br J Clin Pharmacol
; 87(4): 2098-2110, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098714
4.
Spontaneous Formation of Fluorescent Carbon Nanoparticles in Glutaraldehyde Solution and Their Fluorescence Mechanism.
J Fluoresc
; 31(2): 509-516, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33449252
5.
Changes in Disposition of Ezetimibe and Its Active Metabolites Induced by Impaired Hepatic Function: The Influence of Enzyme and Transporter Activities.
Pharmaceutics
; 14(12)2022 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36559237
Resultados
1 -
5
de 5
1
Próxima >
>>